• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1900366 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-01-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-01-08 view
JYSB1400115 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2014-08-14 勃林格殷格翰国际贸易(上海)有限公司 Boehringer Ingelheim International Trading (Shanghai) Co Ltd Certificate Issued 2015-01-15 view
JYSB2200180 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2022-09-19 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSB1700169 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYSB2300147 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2023-08-25 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSB1800119 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYSB0700134 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2007-08-22 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2008-12-22 view
JYSB2000423 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-08-31 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-09-11 view
JYSZ1500004 注射用阿替普酶 alteplase Lyophilized Biological Products License Renew 2015-02-26 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-12-08 view
JYSB2200181 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2022-09-19 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSB1800098 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view
JYSB2400028 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2024-02-06 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSZ2100500 注射用阿替普酶 alteplase Lyophilized Biological Products License Renew 2021-04-01 view
JYSB1700170 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYSB2300148 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2023-08-25 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSB1800118 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYSB2000422 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-08-31 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-09-11 view
JYSZ1500003 注射用阿替普酶 alteplase Lyophilized Biological Products License Renew 2015-02-11 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-12-08 view
JYSB2200123 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2022-07-11 Boehringer Ingelheim Pharma Gmbh & Co KG view
JYSB1800096 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view